Vertex Pharmaceuticals Inc / Ma (VRTX) Cash from Operations (2009 - 2026)

Vertex Pharmaceuticals (VRTX) has reported Cash from Operations for 18 consecutive years, with 1428100000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Operations rose 74.39% year-over-year to 1428100000.0; the TTM figure through Mar 2026 stood at 4240600000.0 (up 532.58% YoY), while the FY2025 annual figure was 3631400000.0, up 837.19% from the prior year.
• Cash from Operations came in at 1428100000.0 for Q1 2026 at Vertex Pharmaceuticals, up from 498000000.0 in the prior quarter.
• The five-year high for Cash from Operations was 1428100000.0 in Q1 2026, with the low at 3753600000.0 in Q2 2024.
• Average Cash from Operations over 5 years is 719652941.18, with a median of 1073100000.0 recorded in 2025.
• Across the five-year window, Cash from Operations soared 670.76% in 2022 and slumped 430.89% in 2024, its largest moves.
• Year by year, Cash from Operations stood at 1078400000.0 in 2022, then tumbled by 78.25% to 234600000.0 in 2023, then jumped by 149.19% to 584600000.0 in 2024, then declined by 14.81% to 498000000.0 in 2025, then soared by 186.77% to 1428100000.0 in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered 1428100000.0, 498000000.0, and 1241400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.